Incontinence

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

C
ColoplastAustralia - Mulgrave
1 program
BiofeedbackN/A1 trial
Active Trials
NCT00653887TerminatedEst. Dec 2009
Pelvital
PelvitalMN - Minneapolis
1 program
Pelvital probeN/A1 trial
Active Trials
NCT02954042Completed120Est. Oct 2019
Zoll
ZollCA - San Jose
1 program
UroCoolN/A1 trial
Active Trials
NCT01920035CompletedEst. Dec 2014
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
lower urinary tract dysfunctionN/A1 trial
Active Trials
NCT02030340UnknownEst. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PelvitalPelvital probe
T-Therapeuticslower urinary tract dysfunction
ZollUroCool
ColoplastBiofeedback

Clinical Trials (4)

Total enrollment: 120 patients across 4 trials

NCT02954042PelvitalPelvital probe

Pelvital Stress Urinary Incontinence Training Device: P-SUIT

Start: Mar 2017Est. completion: Oct 2019120 patients
N/ACompleted
NCT02030340T-Therapeuticslower urinary tract dysfunction

Comparison of Air Charged Catheters With Water Filled Catheters for Urodynamic Study

Start: Dec 2013Est. completion: Dec 2014
N/AUnknown
NCT01920035ZollUroCool

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Start: May 2013Est. completion: Dec 2014
N/ACompleted
NCT00653887ColoplastBiofeedback

Biofeedback and Cortical Excitability

Start: Jan 2008Est. completion: Dec 2009
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space